Evidence map›Paper›PMID 20420489›Full record

ReviewExpert review of neurotherapeutics2010

Causes versus effects: the increasing complexities of Alzheimer's disease pathogenesis.

Siddhartha Mondragón-Rodríguez, Gustavo Basurto-Islas, Hyoung-gon Lee, George Perry, Xiongwei Zhu, Rudy J Castellani, Mark A Smith

Abstract readReview
In one paragraph

Review in Expert review of neurotherapeutics, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Smoking and increased Alzheimer's disease risk: a review of potential mechanisms.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2014
    Pooled it
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Effect of smoking cessation on the risk of dementia: a longitudinal study.Annals of clinical and translational neurology · 2018
    Article
  13. Article
  14. Article
  15. Review
  16. Alpha-synuclein repeat variants and survival in Parkinson's disease.Movement disorders : official journal of the Movement Disorder Society · 2014
    Article
  17. Review
  18. β-Amyloid oligomers in aging and Alzheimer's disease.Frontiers in aging neuroscience · 2013
    Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Siddhartha Mondragón-RodríguezDépartement de Physiologie, Université de Montréal, Québec, Canada.
Gustavo Basurto-Islas
Hyoung-gon Lee
George Perry
Xiongwei Zhu
Rudy J Castellani
Mark A Smith

Funding

Amyloid-beta: The Alternate HypothesisR01AG026151 · NIA · CASE WESTERN RESERVE UNIVERSITY · PI SMITH, MARK A · 2005 to 2007
$741k
NIA NIH HHS AG026151NIA NIH HHS R01 AG026151
6 · The paper itself

Abstract

Amyloid plaques and neurofibrillary tangles are the hallmarks of Alzheimer's disease and have been the focus of disease etiology and pathogenesis. However, in the larger picture of a complex disease, the precise etiology of the lesions per se, as well as the clinical disease, remain to be defined. In this regard, to date no single process has been identified as a useful target and treatment efforts have shown no meaningful progress. Therefore, alternative ideas that may lead to new and effective treatment options are much needed.

Indexed as

Alzheimer DiseaseAmyloid beta-PeptidesCholinesterase InhibitorsHumansModels, BiologicalNeurofibrillary TanglesOxidative StressPlaque, Amyloidtau ProteinsAmyloid beta-PeptidesCholinesterase Inhibitorstau Proteins

Identifiers

PMID20420489
PMCPMC2922904

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.